lincomycin has been researched along with Actinomycosis, Cervicofacial in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Martin, MV | 1 |
Fass, RJ; Hodges, GR; Saslaw, S; Scholand, JF | 1 |
Eastridge, CE; Hughes, FA; McCaughan, JJ; Prather, JR; Young, JM | 1 |
Mohr, JA; Muchmore, HG; Rhoades, ER | 1 |
4 other study(ies) available for lincomycin and Actinomycosis, Cervicofacial
Article | Year |
---|---|
Antibiotic treatment of cervicofacial actinomycosis for patients allergic to penicillin: a clinical and in vitro study.
Topics: Actinomyces; Actinomycosis, Cervicofacial; Adult; Clindamycin; Erythromycin; Female; Humans; Hypersensitivity; Lincomycin; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Penicillins; Tetracycline; Tetracyclines; Time Factors | 1985 |
Clindamycin in the treatment of serious anaerobic infections.
Topics: Abscess; Actinomycosis, Cervicofacial; Adult; Aged; Anaerobiosis; Bacterial Infections; Bacteroides Infections; Bronchial Fistula; Cellulitis; Clindamycin; Empyema; Female; Fistula; Fusobacterium; Gas Gangrene; Humans; Lincomycin; Lung Abscess; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Peptococcus; Pleural Diseases; Pneumonia; Streptococcal Infections | 1973 |
Actinomycosis: a 24 year experience.
Topics: Actinomycosis; Actinomycosis, Cervicofacial; Adult; Chloramphenicol; Demecolcine; Diagnosis, Differential; Follow-Up Studies; Humans; Lincomycin; Lung Diseases, Fungal; Male; Middle Aged; Oral Manifestations; Penicillins; Radiography; Sulfadiazine; Tetracycline | 1972 |
Actinomycosis treated with lincomycin.
Topics: Actinomycosis; Actinomycosis, Cervicofacial; Adult; Female; Humans; Injections, Intramuscular; Lincomycin; Lung Diseases, Fungal; Male; Mandibular Diseases; Middle Aged; Penicillins; Sulfamethoxazole; Tetracycline; Tooth Extraction | 1970 |